Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.

Laidlaw, Tanya M; Chu, Derek K; Stevens, Whitney W; White, Andrew A

Laidlaw, Tanya M; Chu, Derek K; Stevens, Whitney W; White, Andrew A.

Afiliación

Laidlaw TM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Electronic address: tlaidlaw@partners.org.
Chu DK; Department of Medicine, Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, Canada; Department Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Research Institute of St Joe's Hamilton, Hamilton, ON, Canada.
Stevens WW; Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
White AA; Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif.

J Allergy Clin Immunol Pract ; 10(6): 1462-1467, 2022 06.

Article en En | MEDLINE | ID: mdl-34999274

Asunto(s)

Asma Inducida por Aspirina; Productos Biológicos; Pólipos Nasales; Rinitis; Sinusitis; Aspirina/efectos adversos; Asma Inducida por Aspirina/tratamiento farmacológico; Productos Biológicos/uso terapéutico; Enfermedad Crónica; Desensibilización Inmunológica; Humanos; Pólipos Nasales/tratamiento farmacológico; Rinitis/terapia; Sinusitis/tratamiento farmacológico

Palabras clave

AERD; Aspirin desensitization; Aspirin-exacerbated respiratory disease; Benralizumab; Biologics; CRSwNP; Chronic rhinosinusitis; Dupilumab; Mepolizumab; Nasal polyps; Omalizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sinusitis / Productos Biológicos / Rinitis / Pólipos Nasales / Asma Inducida por Aspirina Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google